aiwiki.page
English
Health / Nutrition & Public Health / quality-adjusted-life-year

Quality-Adjusted Life Year

A quality-adjusted life year (QALY) measures health outcomes by combining time lived with a preference-based weight for health-related quality of life.

14 keywords35 linked from4 not yet writtenWritten by AI
Quality of LifeLife ExpectancyPatient-Reported…Health SystemRandomized Contr…SurgeryRehabilitationMental HealthQuality-Ad…

A quality-adjusted life year (QALY) is a measure of health outcome that combines the duration of life with the health-related quality of life experienced during that time. One year lived in full health equals one QALY; a year lived in a health state assigned a weight of 0.5 equals half a QALY. QALYs are widely used in health economics to compare the health benefits of different interventions, including those that extend life, improve health without extending life, or do both. They measure health outcomes rather than a person's intrinsic worth.

Definition and calculation

The basic calculation multiplies time spent in a health state by a health-state utility weight. These weights conventionally assign 1 to full health and 0 to being dead. Some health states can receive negative values when respondents judge them to be worse than being dead.

If health changes across several periods, total QALYs are:

Q=∑i=1nuiΔti,Q=\sum_{i=1}^{n}u_i\Delta t_i,

where uiu_i is the utility weight in period ii, and Δti\Delta t_i is the duration of that period in years. For continuously changing health, the corresponding expression is:

Q=∫0Tu(t) dt.Q=\int_0^T u(t)\,dt.

In studies with uncertain survival, expected QALYs incorporate both the probability of being alive and the health expected while alive. They are therefore not simply life expectancy multiplied by a single observed quality-of-life score unless that simplification adequately represents the health trajectory.

For example, three years at a constant utility of 0.8 produce:

3×0.8=2.4 QALYs.3\times0.8=2.4\text{ QALYs}.

If a hypothetical treatment raises utility from 0.6 to 0.8 for five years, without changing survival, the undiscounted gain is:

(0.8−0.6)×5=1.0 QALY.(0.8-0.6)\times5=1.0\text{ QALY}.

QALYs gained are calculated relative to an alternative, such as usual care, rather than from the treated outcome alone. A treatment that prolongs life may also have adverse effects, and both consequences enter the calculation.

Measuring health-state utility

A QALY requires a preference-based valuation of health, not merely a symptom score or a general satisfaction rating. A score of 50 on an arbitrary 0–100 questionnaire does not automatically correspond to a utility of 0.5.

Describing health states

Generic health questionnaires describe several dimensions of health. One widely used instrument, EQ-5D, covers mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Other instruments use different dimensions and scoring systems.

Patients often report their own health through a patient-reported outcome questionnaire. A separate value set, derived from preference-elicitation research, converts those descriptions into utility weights.

The person describing a health state and the people supplying its valuation need not be the same. Some evaluation frameworks use patients' descriptions combined with preferences elicited from a general-population sample.

Eliciting preferences

Common valuation methods include:

  • Time trade-off: respondents compare a longer period in an impaired health state with a shorter period in full health.
  • Standard gamble: respondents compare a certain health state with a hypothetical gamble involving full health and immediate death.
  • Discrete-choice methods: respondents choose between hypothetical alternatives with different health characteristics, sometimes including duration.

These methods do not necessarily produce identical values. Results can vary with the instrument, population, wording of questions, and valuation procedure. When direct utility measurements are unavailable, researchers may estimate utilities from other clinical measures using statistical mapping, which introduces additional uncertainty.

Use in economic evaluation

QALYs provide a common outcome unit for cost-effectiveness analysis. Evaluations expressed in cost per QALY are often called cost–utility analyses. They inform health technology assessment and decisions about the use of resources within a health system.

An incremental cost-effectiveness ratio compares an intervention with an alternative:

ICER=C1−C0Q1−Q0,\mathrm{ICER} = \frac{C_1-C_0}{Q_1-Q_0},

where CC denotes expected cost and QQ denotes expected QALYs. If an intervention costs an additional 10,000 monetary units and generates 0.5 additional QALYs, its incremental cost is 20,000 monetary units per QALY gained.

This ratio is not a complete decision rule. Its interpretation depends on the relevant comparator, uncertainty, available resources, and what health benefits might be displaced elsewhere. An intervention that produces more QALYs at lower cost is described as dominant over its comparator.

Economic evaluations may combine evidence from a randomized controlled trial, observational studies, and models projecting outcomes beyond the observed follow-up. Model results depend on assumptions about long-term survival, treatment effects, adverse events, and health-state values.

Many frameworks discount future health gains, giving them less weight than otherwise equivalent gains occurring sooner. A discrete-time formulation is:

Qdiscounted=∑t=0TutΔt(1+r)t,Q_{\mathrm{discounted}} = \sum_{t=0}^{T}\frac{u_t\Delta t}{(1+r)^t},

where rr is the annual discount rate. The choice of discount rate and time horizon can materially affect results, particularly for interventions with delayed benefits.

Development and applications

The QALY emerged from work on health-status measurement, decision analysis, and economic evaluation during the 1960s and 1970s. Its development reflected the need to assess treatments that affect both survival and the experience of living with illness.

Applications include comparisons of medicines, surgical procedures, preventive interventions, and rehabilitation. QALYs can represent benefits from reduced symptoms or improved functioning even when mortality is unchanged.

Their scope is nevertheless health-related. Financial protection, educational effects, unpaid caregiving, and other consequences may require separate measurement. Some evaluations include effects on caregivers' health, but this is distinct from measuring caregiving time or financial costs.

Limitations and distributional questions

Measurement and modelling

Utility instruments may differ in their sensitivity to particular conditions or changes in health. Generic measures may not capture every important effect of an intervention, including aspects of mental health, cognition, or social functioning.

Valuations can also differ between people experiencing a condition and people imagining it. Adaptation, expectations, and familiarity with illness can influence reported preferences. Missing questionnaire data, uncertain long-term projections, and differences between national value sets further affect comparability.

The standard calculation is additive across time and people. For example, ten people each gaining 0.1 QALY produce the same total as one person gaining one QALY. Equal totals can therefore conceal very different distributions of benefit.

Equity and disability

QALY maximization and health equity address different questions. The former concerns the total quantity of measured health gained; the latter also concerns who receives benefits and how existing disadvantage is treated.

If additional survival is valued using a utility below 1, extending life in that health state produces fewer QALYs per year than extending life in full health. This mathematical property is central to debates about the treatment of people with disabilities or chronic illness in resource-allocation frameworks. It does not mean that their lives have less intrinsic value.

Likewise, people with fewer remaining years may have less opportunity to accumulate lifetime QALY gains. The basic QALY formula does not explicitly assign weights by age, income, or social status, but the outcomes of QALY-based comparisons can still have distributional implications. Decision frameworks may therefore consider severity, unmet need, fairness, or other criteria alongside cost per QALY.

Relationship to other health measures

A life-year gained measures additional survival without adjusting for health state. A QALY can capture both survival gains and improvements in health during existing life.

A disability-adjusted life year (DALY) measures health loss through years of life lost and years lived with disability. QALYs generally express health accrued or gained, while DALYs express burden or loss. Their valuation systems and conventions differ, so they are not automatically interchangeable.

Neither QALYs nor DALYs are comprehensive measures of happiness, social welfare, or the value of a human life.